SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the availability of its BioXp® Select ...
SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced continued expansion of the BioXp® ...
SAN DIEGO--(BUSINESS WIRE)--SGI-DNA announces the launch of the Multi-Tile Assembly Cloning (MTAC) application for its BioXp™ 3200 System, providing scientists with the ability to synthesize two genes ...
SAN DIEGO--(BUSINESS WIRE)--SGI-DNA, creators of the BioXp™ 3200 System and Gibson Assembly ® Reagents, announces a focused effort to empower organizations to accelerate research focused on creating ...
SGI-DNA Inc. today announced the launch of the BioXp™ 3200 System Early Access Program giving researchers priority access to this one of a kind, personal DNA work station which delivers high quality ...
Telesis Bio Inc., a leader in automated multi-omic and synthetic biology solutions, has announced the availability of its BioXp® Select mRNA Synthesis Kit. This kit enables on-demand and automated ...